
Browsing restrictions can be lifted for a fee.
As of Q4'25, RXRX's current contract liabilities stand at USD 37.61M, representing the latest data point in the series. This marks a significant decrease from the previous quarter, when liabilities were USD 158.57M. From Q1'23 to Q4'25, the chart exhibits notable volatility. After a steady decline from USD 114.85M in Q1'23 to a low of USD 61.37M in Q2'24, there was a sharp spike to USD 180.53M in Q4'24, followed by a gradual decrease through 2025 and a dramatic drop in Q4'25. The data suggests periods of both contraction and sudden expansion in contract liabilities, with the most pronounced change occurring between Q3'25 and Q4'25.